Published January 11, 2022
| Version v1
Dataset
Open
Virtual screening of 2629 Janssen compounds against SARS-CoV-2 RdRP
Description
This short report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 RdRP and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.
Files
Files
(147.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:c28690e52a0a60cd265be6fe4ae230e4
|
147.0 kB | Download |